Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Wingertzahn

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Infectious Diseases and Therapy|February 16, 2026
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19Ilker Yalcin, Leijun Hu, Brandyn West, et al.
Human Psychopharmacology|March 29, 2016
Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trialGary G Kay, Howard I Schwartz, Mark A Wingertzahn, et al.
Digestive Diseases and Sciences|May 14, 2003
Gum arabic (GA) modifies paracellular water and electrolyte transport in the small intestineKhalil U Rehman, Mark A Wingertzahn, Saul Teichberg, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2007
Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitisEli O Meltzer, Sudeesha Kunjibettu, Nancy Hall, et al.
Pulmonary Pharmacology & Therapeutics|April 20, 2011
An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitisPaul Ratner, Mark A Wingertzahn, Rolf Herzog, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2006
Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitisPaul H Ratner, Mark A Wingertzahn, Julius H van Bavel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 15, 2006
Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitisPaul H Ratner, Mark A Wingertzahn, Julius H van Bavel, et al.
Allergy and Asthma Proceedings|September 18, 2012
Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveysEli O Meltzer, Michael S Blaiss, Robert M Naclerio, et al.
Allergy and Asthma Proceedings|June 19, 2010
Nasal allergies in the Latin American population: results from the Allergies in Latin America surveyHugo Neffen, Joao F Mello, Dirceu Sole, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2009
Burden of allergic rhinitis: results from the Pediatric Allergies in America surveyEli O Meltzer, Michael S Blaiss, M Jennifer Derebery, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Infectious Diseases and Therapy|February 16, 2026
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19Ilker Yalcin, Leijun Hu, Brandyn West, et al.
Human Psychopharmacology|March 29, 2016
Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trialGary G Kay, Howard I Schwartz, Mark A Wingertzahn, et al.
Digestive Diseases and Sciences|May 14, 2003
Gum arabic (GA) modifies paracellular water and electrolyte transport in the small intestineKhalil U Rehman, Mark A Wingertzahn, Saul Teichberg, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2007
Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitisEli O Meltzer, Sudeesha Kunjibettu, Nancy Hall, et al.
Pulmonary Pharmacology & Therapeutics|April 20, 2011
An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitisPaul Ratner, Mark A Wingertzahn, Rolf Herzog, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2006
Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitisPaul H Ratner, Mark A Wingertzahn, Julius H van Bavel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 15, 2006
Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitisPaul H Ratner, Mark A Wingertzahn, Julius H van Bavel, et al.
Allergy and Asthma Proceedings|September 18, 2012
Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveysEli O Meltzer, Michael S Blaiss, Robert M Naclerio, et al.
Allergy and Asthma Proceedings|June 19, 2010
Nasal allergies in the Latin American population: results from the Allergies in Latin America surveyHugo Neffen, Joao F Mello, Dirceu Sole, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2009
Burden of allergic rhinitis: results from the Pediatric Allergies in America surveyEli O Meltzer, Michael S Blaiss, M Jennifer Derebery, et al.
Pageof 2